MULTIPLE SCLEROSIS (MS) SECONDARY PROGRESSIVE
Clinical trials for MULTIPLE SCLEROSIS (MS) SECONDARY PROGRESSIVE explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS (MS) SECONDARY PROGRESSIVE trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS (MS) SECONDARY PROGRESSIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New MS drug trial uses Super-Strength MRI to see inside the brain
Disease control Not yet recruitingThis study tests an experimental drug called remibrutinib in 20 people with relapsing or progressive multiple sclerosis (MS). Participants take the drug twice daily for 2 years, and researchers use ultra-powerful 7T MRI scans to measure changes in brain volume, lesions, and tissu…
Matched conditions: MULTIPLE SCLEROSIS (MS) SECONDARY PROGRESSIVE
Phase: PHASE2 • Sponsor: Moein Amin • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Experimental CAR-T therapy targets Hard-to-Treat MS in small safety trial
Disease control Not yet recruitingThis early-stage study tests a new treatment called S103 (BCMA-CAR T cells) for people with progressive or hard-to-treat multiple sclerosis (MS). The main goal is to check if the treatment is safe and to find the right dose. Only 9 adults will take part, and the study is not yet …
Matched conditions: MULTIPLE SCLEROSIS (MS) SECONDARY PROGRESSIVE
Phase: PHASE1 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
Could clearing old cells boost brain and body in MS patients?
Symptom relief Not yet recruitingThis early-stage study tests whether a combination of two drugs (dasatinib and quercetin) is safe and can help improve physical and thinking abilities in older adults with secondary progressive multiple sclerosis (MS). The drugs work by removing aged, damaged cells that may fuel …
Matched conditions: MULTIPLE SCLEROSIS (MS) SECONDARY PROGRESSIVE
Phase: PHASE1 • Sponsor: Ohio State University • Aim: Symptom relief
Last updated May 26, 2026 03:09 UTC